Fresenius SE & Co. KGaA 最大收入来源是 Fresenius Kabi,在最近的收益报告中收入为 8,612,000,000。就地区而言, North America 是 Fresenius SE & Co. KGaA 的主要市场,收入为 2,701,000,000。
Fresenius SE & Co. KGaA 是否盈利?
是的,根据最新的财务报表,Fresenius SE & Co. KGaA 的净利润为 $1,264
Fresenius SE & Co. KGaA 有负债吗?
不,Fresenius SE & Co. KGaA 的负债为 0
Fresenius SE & Co. KGaA 的流通股有多少?
Fresenius SE & Co. KGaA 的总流通股为 0
关键数据
前收盘价
$12.72
开盘价
$12.47
当日区间
$12.45 - $12.66
52周范围
$9.78 - $33.93
交易量
24.7K
平均成交量
77.1K
股息收益率
--
每股收益(TTM)
0.59
市值
$28.3B
什么是 Fresenius SE & Co. KGaA?
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.